Replies to post #137783 on Cytodyn Inc (CYDY)

[Learning53]

I'll lift a glass to that

AND

Leronlimab/Vyrologix will be saving lives, restoring function, bringing hope and well being.

Just about everybody wins

Except some not so big winners:
Maybe shorts learn a valuable lesson and BP will learn to adapt

As an after-thought:
As leronlimab's MOA generally involves CCR5 and that specificity was achieved by creating a monoclonal antibody (a "mab"), what other channels into the cells can be "mabbed?" Maybe (this is out-there, especially considering we currently have no income) keeping an eye on what else is starting up new, promising, and is appropriate to our expertise/knowledge base - for future acquisitions. While we have a great number of indications to explore, we're still a one-pony show. I plan to hold this for a while - not into eating dust...

I'll also query, is the acquisition of Incelldx a far-fetched idea?

[Yki]

Sounds good.. except one tiny mistake..
"Northern Lights in Sweden" .. they are better and safe here in Finland ;)

[dadbrotheroftwins]

My thoughts exactly! Although I hope FDA expedites EAU like they did for Remdesivir I'm not sure that will happen. I believe that leronlimab will be the SOC for therapeutic treatments for many indications for years to come because of it's MOA. I don't think that people realize how big this market will be.

[ClosetInvestor]

“I would hope that NP/CYDY would have the CD12 results completely processed and the EUA paperwork submitted to the US FDA by Valentines Day. THEN he can drop a PR.”

Probably the most reasonable timeline I’ve seen posted, although I expect a PR announcing the data in January and EUA submission in February.

“After that he can PR that Maboob has submitted the US HIV BLA.”

We’ll see what’s said this week during the CC about HIV, but I don’t expect the US HIV BLA to be filed for a couple of more months, maybe longer. If NP is being truthful about the FDA wanting RO data, CYDY’s new lab has to complete development of the RO (which is likely complete by now) and then they’ll need to collect new blood samples from the 700mg patients to conduct the RO on. That’ll take time, especially considering that some of the 700mg patients may not be in the trial any longer.

“While we're out shopping for our Lambos, Hatterases (??), and F650's....NP will PR that the Phase 3 for NASH has been approved.”

I’m assuming you’re being sarcastic about the NASH 3 phase 3 announcement, as the phase 2 trial has yet to fully enroll, but the electric Porsche’s are more my thing.